View Item 

Show simple item record

Linezolid Clearance During Continuous Venovenous Hemodiafiltration: A Case Report

dc.contributor.authorKraft, Michael D.en_US
dc.contributor.authorPasko, Deborah A.en_US
dc.contributor.authorDePestel, Daryl D.en_US
dc.contributor.authorEllis, Jessica J.en_US
dc.contributor.authorPeloquin, Charles A.en_US
dc.contributor.authorMueller, Bruce A.en_US
dc.date.accessioned2012-03-16T15:56:41Z
dc.date.available2012-03-16T15:56:41Z
dc.date.issued2003-08en_US
dc.identifier.citationKraft, Michael D.; Pasko, Deborah A.; DePestel, Daryl D.; Ellis, Jessica J.; Peloquin, Charles A.; Mueller, Bruce A. (2003). "Linezolid Clearance During Continuous Venovenous Hemodiafiltration: A Case Report." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23(8). <http://hdl.handle.net/2027.42/90207>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90207
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.titleLinezolid Clearance During Continuous Venovenous Hemodiafiltration: A Case Reporten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Clinical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumDepartment of Pharmacy Services, University of Michigan Health System, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherInfectious Diseases Pharmacokinetics Laboratory, National Jewish Medical and Research Center, Denver, Colorado.en_US
dc.identifier.pmid12921253en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90207/1/phco.23.8.1071.32874.pdf
dc.identifier.doi10.1592/phco.23.8.1071.32874en_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceShaikh, Z.H., Peloquin, C.A., Ericsson, C.D.. Successful treatment of vancomycin‐resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 2001; 33: 375 – 9.en_US
dc.identifier.citedreferencePfaller, M.A., Jones, R.N., Doern, G.V., and Kugler, K.. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 1998; 42: 1762 – 70.en_US
dc.identifier.citedreferenceFridkin, S.K., Gaynes, R.P.. Antimicrobial resistance in intensive care units. Clin Chest Med 1999; 20: 303 – 16.en_US
dc.identifier.citedreferenceAntony, S.J., Bitter, K.M., Moreland, T., Raudales, F., Diaz‐Luna, H.. Methicillin‐resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms. Clin Infect Dis 1999; 29: 1341 – 2.en_US
dc.identifier.citedreferenceMelzer, M., Goldsmith, D., Gransden, W.. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant Enterococcus bacteremias. Clin Infect Dis 2000; 31: 208 – 9.en_US
dc.identifier.citedreferenceBassetti, M., DiBiagio, A., Cenderello, G., et al. Linezolid treatment of prosthetic hip infections due to methicillin‐resistant Staphylococcus aureus (MRSA). J Infect 2001; 43: 148 – 9.en_US
dc.identifier.citedreferenceRubinstein, E., Cammarata, S.K., Oliphant, T.H., Wunderink, R.G.. Linezolid (PNU‐100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double‐blind, multicenter study. Clin Infect Dis 2001; 32: 402 – 12.en_US
dc.identifier.citedreferenceStevens, D.L., Herr, D., Lampiris, H., et al. Linezolid versus vancomycin for the treatment of methicillin‐resistant Staphylococcus aureus infections. Clin Infect Dis 2002; 34: 1481 – 90.en_US
dc.identifier.citedreferenceTill, M., Wixson, R.L., Pertel, P.E.. Linezolid treatment for osteomyelitis due to vancomycin‐resistant Enterococcus faecium. Clin Infect Dis 2002; 34: 1412 – 14.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565 – 7.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Vancomycin‐resistant Staphylococcus aureus: Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 902.en_US
dc.identifier.citedreferenceMehta, R.L., Letteri, J.M.. Current status of renal replacement therapy for acute renal failure. Am J Nephrol 1999; 19: 377 – 82.en_US
dc.identifier.citedreferencePharmacia & Upjohn Company. Zyvox (linezolid) package insert. Kalamazoo, MI; 2000.en_US
dc.identifier.citedreferenceBrier, M.E., Stalker, D.J., Aronoff, G.R., et al. Pharmacokinetics of linezolid in subjects with varying degrees of renal function and on dialysis [abstr]. J Investig Med 1998; 46: 276A.en_US
dc.identifier.citedreferenceJoy, M.S., Matzke, G.R., Armstrong, D.K., Marx, M.A., Zarowitz, B.J.. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 1998; 32: 362 – 75.en_US
dc.identifier.citedreferenceClemett, D., Markham, A.. Linezolid. Drugs 2000; 59: 815 – 27.en_US
dc.identifier.citedreferenceZurenko, G.E., Gibson, J.K., Shinabarger, D.L., Aristoff, P.A., Ford, C.W., Tarpley, W.G.. Oxazolidinones: a new class of antibacterials. Curr Opin Pharmacol 2001; 1: 470 – 6.en_US
dc.identifier.citedreferenceMauro, L.S., Sharief, I., Assaly, R., Malhotra, D.. Determination of linezolid clearance via continuous hemodiafiltration [abstr]. Pharmacotherapy 2001; 21: 1279.en_US
dc.identifier.citedreferenceReetze‐Bonorden, P., Bohler, J., Keller, E.. Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 1993; 24: 362 – 79.en_US
dc.identifier.citedreferenceSchetz, M., Ferdinande, P., Van den Berghe, G., Verwaest, C., Lauwers, P.. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 1995; 21: 612 – 20.en_US
dc.identifier.citedreferenceGolper, T.A.. Drug removal during continuous hemofiltration or hemodialysis. Contrib Nephrol 1991; 93: 110 – 16.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
phco.23.8.1071.32874.pdf
Size:
104.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.